Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVd Combination in Multiple Myeloma
NCT00003493Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Nov 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in multiple myeloma (MM), sponsored by Cleveland Clinic. Started Nov 1998; status: completed.
02
Drugs
doxorubicin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00003493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003493.